Aimmune

@aimmune

Aimmune is a clinical-stage biopharmaceutical company. Our mission is to improve the lives of people with food allergies. Guidelines:

Vrijeme pridruživanja: travanj 2015.

Tweetovi

Blokirali ste korisnika/cu @aimmune

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @aimmune

  1. prije 12 sati

    The continued investment from announced today supports our mutual goal of developing innovative therapies for . Read our full release here:

    Poništi
  2. prije 12 sati

    Today’s announcement is an exciting step toward further evolving the therapeutic landscape of treatments. Read more here:

    Poništi
  3. 4. velj

    We also greatly appreciate the critical work by all RAMSES physician investigators and their staff – thank you for your support

    Prikaži ovu nit
    Poništi
  4. 4. velj

    Thank you to all of the PALISADE physician investigators and their staff who worked tirelessly to help get us to this approval

    Prikaži ovu nit
    Poništi
  5. 3. velj

    We want to recognize the enormous amount of effort from groups like , , , and , whose advocacy and collaboration have been instrumental in supporting the FDA approval of the first treatment.

    Prikaži ovu nit
    Poništi
  6. 1. velj

    We also want to acknowledge the more than 1,200 patients and their families who participated in our clinical trials. Thank you for your support – without you, this FDA-approval would not have been possible!

    Prikaži ovu nit
    Poništi
  7. 1. velj

    Thank you to all Aimmune employees for your incredible work leading up to this FDA-approval! Your dedication has helped bring this important treatment option to patients and their families.

    Prikaži ovu nit
    Poništi
  8. 31. sij

    BREAKING NEWS: We’re proud to announce FDA approval of the first treatment for . Read our release and the full Prescribing Information, including Boxed WARNING, and Medication Guide:

    Prikaži ovu nit
    Poništi
  9. 31. sij

    We look forward to participating in this year's CICBAA Symposium this weekend in Brussels, Belgium. For those attending, be sure to stop by our booth to meet the Aimmune team.

    Poništi
  10. 14. sij

    Another great year at in the books! Our team looks forward to continued progress and innovation throughout 2020.

    Poništi
  11. 13. sij

    Join us this afternoon to hear CEO Jayson Dallas speak at

    Poništi
  12. 10. sij

    Heading to – looking forward to presenting on Monday! See you there.

    Poništi
  13. 9. sij

    The number of children living with a continues to increase each year. Our team remains committed to providing treatment options for families affected. Learn more:

    Poništi
  14. 1. sij

    Wishing you and your families a ! We look forward continuing our work for patients and families with in the new year.

    Poništi
  15. 23. pro 2019.

    Happy Holidays from all of us at Aimmune! We wish you and your families a joyous season.

    Poništi
  16. 18. pro 2019.

    Traveling internationally this holiday season? Don't forget regulations around food labels vary country to country. Find tips for managing while on vacation via

    Poništi
  17. 16. pro 2019.

    Holiday parties are a time of joy and celebration, but can be difficult to navigate when you have a . Read tips on how to stay safe during the holidays from :

    Poništi
  18. 12. pro 2019.

    Today is the start of the Annual Congress in Lyon, France. Stop by our booth to learn more about our research on

    Poništi
  19. 29. stu 2019.

    It's the start of the NAPPA Congress in Sylt, Germany where future treatments for pediatric food allergy will be discussed. Stop by the Aimmune booth to meet our local team!

    Poništi
  20. 25. stu 2019.

    Trying a new restaurant abroad? Chef cards are a helpful way to communicate foods that must be avoided due to . Download cards from here:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·